This population-based retrospective cohort study assesses rates of adverse events (AE) after COVID-19 products experienced by women of reproductive age, focusing on pregnancy and menstruation, using data collected by the Vaccine Adverse Events Reporting System (VAERS) database from Jan 1, 1998, to Jun 30, 2022. LINK in BIO.